Admission Hyperglycemia in Non-diabetics Predicts Mortality and Disease Severity in COVID-19: a Pooled Analysis and Meta-summary of Literature

[1]  Sheng-wei Jin,et al.  J-shaped association between fasting blood glucose levels and COVID-19 severity in patients without diabetes , 2020, Diabetes Research and Clinical Practice.

[2]  A. Maran,et al.  Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration , 2020, Diabetes Research and Clinical Practice.

[3]  L. Ghiadoni,et al.  Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study , 2020, Diabetes Care.

[4]  Wei Wang,et al.  Hyperglycemia is a strong predictor of poor prognosis in COVID-19 , 2020, Diabetes Research and Clinical Practice.

[5]  Yu Hu,et al.  Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019 , 2020, Frontiers in Endocrinology.

[6]  Feng Wu,et al.  Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study , 2020, Diabetologia.

[7]  Lihua Lai,et al.  Fasting blood glucose predicts the occurrence of critical illness in COVID-19 patients: A multicenter retrospective cohort study , 2020, Journal of Infection.

[8]  A. Brufsky,et al.  Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID‐19 , 2020, medRxiv.

[9]  Q. Lv,et al.  Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study , 2020, BMJ open diabetes research & care.

[10]  Lulu Chen,et al.  Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID‐19 , 2020, Diabetes, obesity & metabolism.

[11]  G. Paolisso,et al.  Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control? , 2020, Diabetes Care.

[12]  D. Klonoff,et al.  Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States , 2020, Journal of diabetes science and technology.

[13]  G. Iacobellis,et al.  Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes , 2020, Diabetes Research and Clinical Practice.

[14]  Hong Zhang,et al.  The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single‐centre, retrospective, observational study in Wuhan , 2020, Diabetes, obesity & metabolism.

[15]  R. Pranata,et al.  Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[16]  A. Brufsky.  Hyperglycemia, hydroxychloroquine, and the COVID‐19 pandemic , 2020, Journal of medical virology.

[17]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[18]  C. Midgley,et al.  Diabetes Mellitus, Hypertension, and Death among 32 Patients with MERS-CoV Infection, Saudi Arabia , 2020, Emerging infectious diseases.

[19]  K. Nugent,et al.  The Effect of Short‐Term Hyperglycemia on the Innate Immune System , 2016, The American journal of the medical sciences.

[20]  C. Schumann,et al.  Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study , 2012, BMJ : British Medical Journal.

[21]  Jin-Kui Yang,et al.  Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes , 2009, Acta Diabetologica.

[22]  R. Testa,et al.  Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting. , 2009, Journal of the American College of Cardiology.

[23]  J. Chan,et al.  Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[24]  Brian H Rowe,et al.  The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. , 2005, Diabetes care.

[25]  A. Aljada,et al.  Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. , 2000, The Journal of clinical endocrinology and metabolism.